Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209098 · ClinicalTrials.gov registry record
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
A clinical trial of Heart Failure and Reduced Ejection Fraction and NYHA Class III Heart Failure, sponsored by Impulse Dynamics.
- Recruiting
- Registry status
- 4,200
- Enrollment target
- 1
- Study location
NCT07209098 is a study of Heart Failure and Reduced Ejection Fraction and NYHA Class III Heart Failure that is actively recruiting participants, run by Impulse Dynamics. The registered enrollment target is 4,200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07209098, a study of Heart Failure and Reduced Ejection Fraction and NYHA Class III Heart Failure, is actively recruiting participants, sponsored by Impulse Dynamics.
- RECRUITING
- Registry status
- 4,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective, multi-center, propensity-matched coverage with evidence development (CED) study is to assess the impact of cardiac contractility modulation (CCM) on mortality and heart failure hospitalizations in Medicare-eligible patients with heart failure who meet indications for CCM.
Conditions Studied
Interventions
- DEVICE Cardiac Contractility Modulation (CCM)
Study Locations (1)
New Jersey
- Impulse Dynamics - Marlton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,200 participants |
| Start Date | 2025-11 |
| Est. Completion | 2031-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07209098
The ClinicalTrials.gov registry entry for NCT07209098 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Impulse Dynamics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure and Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Contractility Modulation (CCM) is the first listed.
NCT07209098 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07209098 about?
NCT07209098 is a clinical study titled "Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure". The purpose of this prospective, multi-center, propensity-matched coverage with evidence development (CED) study is to assess the impact of cardiac contractility modulation (CCM) on mortality and heart failure hospitalizations in Medicare-eligible patients with heart failure who meet indications for...
What is the current status of trial NCT07209098?
This trial is currently recruiting. The enrollment target is 4,200 participants. The study started on 2025-11. Estimated completion is 2031-04.
What conditions does trial NCT07209098 study?
This clinical trial studies the following conditions: Heart Failure and Reduced Ejection Fraction, NYHA Class III Heart Failure.
What interventions are being tested in trial NCT07209098?
The interventions under investigation include: Cardiac Contractility Modulation (CCM) (DEVICE).
Who is sponsoring clinical trial NCT07209098?
This trial is sponsored by Impulse Dynamics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07209098 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure and Reduced Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Heart Failure and Reduced Ejection Fraction
All registered trials for this condition
NYHA Class III Heart Failure
All registered trials for this condition
New Jersey
All trials with a study site in New Jersey
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.